表紙
市場調査レポート

生検装置:技術および世界市場

Biopsy Devices: Technology and Global Markets

発行 BCC Research 商品コード 305964
出版日 ページ情報 英文 141 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.75円で換算しております。
Back to Top
生検装置:技術および世界市場 Biopsy Devices: Technology and Global Markets
出版日: 2016年03月28日 ページ情報: 英文 141 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

世界の生検装置市場は2015年に15億米ドルに達しました。同市場はCAGR6.2%の規模で今後も拡大し、2020年には21億米ドルになると予測されています。

当レポートでは、世界の生検装置市場の概要と市場の動向、近年の市場データ、今後の市場予測、セグメント別分析、特許動向、業界に参入する主な企業の包括的プロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 生検装置市場概要

  • 乳房疾患における真空補助下乳房生検システムの役割
  • 慢性肝疾患のための肝臓生検の適応動向
  • 画像誘導前立腺生検:従来技術と新興技術
  • 前立腺生検動向
  • 癌診断と画像市場(マンモグラフィ、大腸内視鏡、内視鏡)
  • 生検装置市場のための法規制シナリオ
  • 償還シナリオ
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会/課題
  • ケーススタディ

第4章 生検装置市場:種類別

  • 乳房生検装置
  • 胃腸生検
  • 軟部組織生検針
  • 気管支生検装置
  • 婦人科生検装置
  • ロボットガイダンスシステム
  • その他

第5章 生検装置市場:治療分野別

  • 乳房生検
  • 前立腺生検
  • 肝生検
  • 肺生検
  • 腎生検
  • 婦人科生検
  • その他

第6章 生検装置市場:画像誘導技術別

  • 誘導生検で使われる画像技術
  • 超音波誘導生検
  • CT(コンピューテッドトモグラフィー)
  • その他

第7章 生検装置:エンドユーザー市場

  • 診断センター
  • 病院

第8章 競合環境

  • 製品上市
  • 提携および協業
  • 買収
  • 拡大

第9章 生検装置市場:地域別

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の地域

第10章 特許分析

第11章 企業プロファイル

  • ARGON MEDICAL DEVICES INC.
  • BECTON DICKINSON AND CO. (CAREFUSION CORP.)
  • BOSTON SCIENTIFIC CORP.
  • C. R. BARD INC.
  • CARDINAL HEALTH INC.
  • COOK MEDICAL INC.
  • DTR MEDICAL LTD.
  • ETHICON ENDO-SURGERY INC.
  • 富士フイルムホールディングス
  • HOLOGIC INC.
  • INRAD INC.
  • INTACT MEDICAL CORP.
  • LEICA BIOSYSTEMS (DEVICOR MEDICAL PRODUCTS)
  • MAUNA KEA TECHNOLOGIES
  • MDNA LIFE SCIENCES INC. (MITOMICS INC.)
  • MDXHEALTH INC.
  • MEDTRONIC
  • SANARUS TECHNOLOGIES LLC
  • VERAN MEDICAL TECHNOLOGIES

第12章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: HLC171B

REPORT HIGHLIGHTS

The global market for biopsy devices should reach around roughly $2.1 billion by 2020 from over $1.5 billion in 2015, a compound annual growth rate (CAGR) of 6.2% from 2015 to 2020.

This report provides:

  • An overview of the global biopsy devices market.
  • Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020
  • Segmented analyses based on devices, therapeutic segments, and geographies
  • Information on key devices such as breast biopsy devices, CNB (core needle biopsy) devices, fine needles, gastro intestinal (GI) biopsy devices, robotic guidance systems technologies involved in thermal ablation techniques and non-thermal ablation techniques
  • Analyses of key strategies, competitive insights, and developments of key companies in the market
  • Information on both the challenges that must be addressed and opportunities that can be leveraged by market participants
  • Evaluation of key and relevant patents
  • Analysis of the key strategies, competitive insights and development of key companies in the market

SCOPE OF THE REPORT

This research report presents an in-depth analysis of the global market for biopsy devices by device type, therapeutic segments and geographic markets. It discusses key devices such as breast biopsy devices, core needle biopsy (CNB) devices, fine needles, gastrointestinal (GI) biopsy devices, robotic guidance systems technologies involved in thermal ablation techniques and nonthermal ablation techniques. The market by type of procedure is also discussed, which includes trends and market estimates of key therapeutic areas such as breast cancer, gastrointestinal cancer, lung cancer and cervical cancer, among others. The report focuses on key imaging technologies used in the process of performing biopsies such as ultrasound, magnetic resonance imaging (MRI), computed tomography (CT) and others. The report also reviews the supply chain from manufacturers to surgeons.

The report excludes drugs used during a biopsy and any device that is used in the cancer treatment process.

ANALYST'S CREDENTIALS

Yojana Jeevane has more than four years of experience in market intelligence and business research. She has experience in the healthcare domain with respect to medical devices, the life sciences market and chemical domain. Ms. Jeevane has provided research services that contain strategic recommendations to assist market players in making beneficial decisions. Yojana holds a B.Sc in Biotechnology and an MBA in Marketing.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY OBJECTIVES
  • STUDY BACKGROUND
  • SCOPE OF THE REPORT
  • INTENDED AUDIENCE
  • METHODOLOGY AND INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - EXECUTIVE SUMMARY

  • SUMMARY TABLE: GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, 2014-2020 ($ MILLIONS)

CHAPTER 3 - OVERVIEW OF BIOPSY DEVICE MARKET

  • VACUUM-ASSISTED BREAST BIOPSY
    • ADVANTAGES OF VAB TECHNIQUE
    • DISADVANTAGES OF VAB TECHNIQUE
  • LIVER BIOPSY TRENDS
    • LIVER DISEASE FACTS
    • PERCUTANEOUS LIVER BIOPSY
    • LAPAROSCOPIC SURGERY
  • PROSTATE BIOPSY TRENDS
    • IMAGE-GUIDED PROSTATE BIOPSY
    • RISKS OF BIOPSY OF THE PROSTATE
  • CANCER DIAGNOSTICS AND IMAGING
    • MAMMOGRAPHY
    • COLONOSCOPY
    • ENDOSCOPY
  • REGULATION OF BIOPSY DEVICES
    • U.S. REGULATION OF BIOPSY DEVICES
    • EU REGULATION OF BIOPSY DEVICES
      • Breast Cancer
        • TABLE 1: IMPLEMENTATION OF BREAST CANCER SCREENING PROGRAMS BY COUNTRY
      • Gastroenterology and Urology
    • REIMBURSEMENT POLICIES
      • U.S. REIMBURSEMENT FOR BREAST CANCER SCREENING
      • U.S. REIMBURSEMENT FOR BREAST RECONSTRUCTION OR PROSTHESIS
      • U.S. REIMBURSEMENT UNDER THE WHCRA
      • U.S. REIMBURSEMENT UNDER THE AFFORDABLE CARE ACT
  • MARKET DYNAMICS
    • DRIVERS
      • Increase in Prevalence of Chronic Diseases
      • Minimally Invasive Procedures as Compared with Other Techniques
      • Increased Public Awareness of Disease Screening
      • Increasing Aging Population
        • TABLE 2: GLOBAL TRENDS IN AGING POPULATION BY REGION, 1980-2040 (%)
        • FIGURE 1: GLOBAL TRENDS IN AGING POPULATION, 1980-2040 (%)
      • Strong Reimbursement Policies in Developing Economies
      • Technological Advancements in Imaging Technology
    • RESTRAINTS
      • Increased Competition from Other Cancer Diagnostic Tests
      • High Price of Advanced Biopsy Devices
      • Availability of Advanced Diagnostic Services
    • OPPORTUNITIES/CHALLENGES
      • Tapping the Diagnostic Market Present in Emerging Economies
        • TABLE 3: PERCENTAGE OF THE AGING POPULATION IN DEVELOPING COUNTRIES, 2014 (%)
        • FIGURE 2: PERCENTAGE OF THE AGING POPULATION IN DEVELOPING COUNTRIES, 2014 (%)
  • CASE STUDIES
    • CASE STUDY 1: BREAST TOMOSYNTHESIS BIOPSY (2011)
      • Company Involved: Hologic Inc.
    • CASE STUDY 2: PET-GUIDED BREAST BIOPSY (2011)
      • Company Involved: Naviscan Inc.
    • CASE STUDY 3: BIOPSY USED TO INFILTRATE DUCTAL CARCINOMA
      • Company Involved: Toshiba

CHAPTER 4 - BIOPSY DEVICE MARKET BY TYPE

  • TABLE 4: GLOBAL MARKET FOR BIOPSY DEVICES BY TYPE, THROUGH 2020 ($ MILLIONS)
  • BREAST BIOPSY DEVICES
    • STEREOTACTIC BIOPSIES
    • ULTRASOUND-GUIDED BIOPSIES
    • SURGICAL OR OPEN BIOPSIES
      • Surgical Biopsies with Needle Localization
        • TABLE 5: GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY TYPE, THROUGH 2020 ($ MILLIONS)
        • TABLE 6: TYPES OF BREAST BIOPSY AND MAMMOGRAPHY EQUIPMENT
        • TABLE 7: GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • VACUUM-ASSISTED BIOPSY DEVICES
      • TABLE 8: GLOBAL MARKET FOR VACUUM-ASSISTED BREAST BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
      • Breast Tissue Markers
        • Advantages of Vacuum-assisted Biopsy
        • Disadvantages of Vacuum-Assisted Biopsy
    • CAPITAL EQUIPMENT
    • IMAGE-GUIDED BREAST BIOPSIES
      • Ultrasound-Guided Breast Core Needle Biopsy
      • Stereotactic/MRI Breast Biopsy (Mammotome)
    • MAMMOGRAPHY
      • Digital Mammography
    • MAGNETIC RESONANCE IMAGING
      • Risks and Benefits of MRI
    • DISPOSABLE DEVICES
      • VAB Disposable Devices
        • Handheld Disposable Devices
      • Disposable Biopsy Punch
        • Punches with Plunger System
        • Punches without Plunger System
    • CORE NEEDLE BIOPSY
      • TABLE 9: GLOBAL MARKET FOR CORE NEEDLE BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
      • Core Needle Biopsy with Stereotactic Mammography
      • Advantages of Core Needle Biopsy
      • Disadvantages of Core Needle Biopsy
      • CNB Disposable Devices
        • Drapes
          • Table Drapes
          • Disposable Magnetic Drapes
          • Equipment Drape
        • Source Sleeve
        • Disposable Sterile Kit
      • CNB Tissue Markers
        • Advantages of CNB Tissue Markers
        • Disadvantages of CNB Markers
    • FINE NEEDLE ASPIRATION BIOPSY
      • TABLE 10: GLOBAL MARKET FOR FINE-NEEDLE ASPIRATION BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
  • GASTROINTESTINAL BIOPSY
    • TABLE 11: GLOBAL MARKET FOR GASTROINTESTINAL BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • COLD FORCEPS
    • HOT FORCEPS
  • SOFT TISSUE BIOPSY NEEDLES
    • TABLE 12: GLOBAL MARKET FOR SOFT TISSUE BIOPSY NEEDLES BY REGION, THROUGH 2020 ($ MILLIONS)
    • CORE NEEDLE BIOPSY NEEDLES
    • FINE-NEEDLE ASPIRATION NEEDLES
      • Advantages of FNA Needles
      • Disadvantages of FNA Needles
  • BRONCHIAL BIOPSY DEVICES
    • TABLE 13: GLOBAL MARKET FOR BRONCHIAL BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • FORCEPS
      • Disposable
      • Reusable
    • TBNA NEEDLES
      • Conventional Needles
    • EBUS-TBNA
  • GYNECOLOGICAL BIOPSY DEVICES
    • TABLE 14: GLOBAL MARKET FOR GYNECOLOGICAL BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • ENDOMETRIAL SAMPLERS
      • Functions of Endometrial Samplers
  • ROBOTIC GUIDANCE SYSTEMS
    • TABLE 15: GLOBAL MARKET FOR ROBOTIC GUIDANCE SYSTEMS BY REGION, THROUGH 2020 ($ MILLIONS)
    • NEUROMATE (RENISHAW)
      • Benefits of Neuromate
      • Safety Features of Neuromate
    • PATHFINDER (PROSURGICS)
    • INNOMOTION (INNOMEDIC)
  • OTHERS
    • TABLE 16: GLOBAL MARKET FOR OTHER BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • BIOPSY BRUSHES
    • BIOPSY CURETTES
      • TABLE 17: TYPES OF BIOPSY CURETTES
    • BIOPSY PUNCHES
      • TABLE 18: TYPES OF BIOPSY PUNCHES

CHAPTER 5 - BIOPSY DEVICE MARKET BY THERAPEUTIC AREA

  • TABLE 19: GLOBAL MARKET FOR BIOPSY DEVICES BY THERAPEUTIC AREA, THROUGH 2020 ($ MILLIONS)
  • TABLE 20: GLOBAL MARKET FOR BIOPSY DEVICE BY NUMBER OF PROCEDURES, THROUGH 2020 (THOUSANDS)
  • BREAST BIOPSY
    • FINE-NEEDLE ASPIRATION BIOPSY
      • Fine-Needle Aspiration Biopsy for Palpable Growth
      • Guided FNAB for Nonpalpable Growth
    • CORE NEEDLE BIOPSY
    • VACUUM-ASSISTED BIOPSIES
    • SURGICAL BIOPSY
      • TABLE 21: GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
  • GI BIOPSY
    • ENDOSCOPIC BIOPSY
    • FINE NEEDLE ASPIRATION BIOPSY
    • SURGICAL BIOPSY
      • TABLE 22: GLOBAL MARKET FOR GI BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
  • PROSTATE BIOPSY
    • LYMPH NODE BIOPSY
      • Laparoscopic Biopsy
      • Fine-Needle Aspiration Biopsy
      • Surgical Biopsy
        • TABLE 23: GLOBAL MARKET FOR PROSTATE BIOPSY DEVICES THROUGH 2020 ($ MILLIONS)
  • LIVER BIOPSY
    • NEEDLE BIOPSY
    • LAPAROSCOPIC BIOPSY
    • SURGICAL BIOPSY
      • TABLE 24: GLOBAL MARKET FOR LIVER BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • LUNG BIOPSY
      • TABLE 25: FIVE YEAR SURVIVAL RATES FOR NON-SMALL LUNG CANCER BY STAGE, 2013 (%)
      • FIGURE 3: FIVE-YEAR SURVIVAL RATE FOR NON-SMALL LUNG CANCER BY STAGE, 2013 (%)
  • ADVANTAGES OF LUNG BIOPSY
  • DISADVANTAGES OF LUNG BIOPSY
    • TABLE 26: GLOBAL MARKET FOR LUNG BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
  • KIDNEY BIOPSY
    • TABLE 27: INCIDENCE OF KIDNEY CANCER IN THE U.S. BY GENDER, 2014 (%)
    • FIGURE 4: INCIDENCE OF KIDNEY CANCER IN THE U.S. BY GENDER, 2014 (%)
    • COMPLICATIONS OF BIOPSIES TO DETECT KIDNEY DISEASE
    • ADVANTAGES OF RENAL/KIDNEY BIOPSY
    • DISADVANTAGES OF RENAL/KIDNEY BIOPSY
      • TABLE 28: GLOBAL MARKET FOR KIDNEY BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
  • GYNECOLOGICAL BIOPSY
    • TABLE 29: DISTRIBUTION OF GYNECOLOGICAL CANCERS IN THE U.S. BY TYPE, 2014
    • FIGURE 5: DISTRIBUTION OF GYNECOLOGICAL CANCERS IN THE U.S. BY TYPE, 2014
    • COMPLICATIONS OF GYNECOLOGICAL BIOPSY
      • TABLE 30: GLOBAL MARKET FOR GYNECOLOGICAL BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
  • BIOPSY DEVICES USED TO DIAGNOSE OTHER DISEASES
    • PANCREATIC CANCER BIOPSY
      • Types of Biopsies Performed to Detect Pancreatic Cancer
      • Percutaneous Needle Biopsy
      • Endoscopic Retrograde Cholangiopancreatography
      • Endoscopic Ultrasound
    • BILE DUCT CANCER BIOPSY
    • THYROID BIOPSY
      • TABLE 31: GLOBAL MARKET FOR OTHER THERAPEUTIC BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)

CHAPTER 6 - BIOPSY DEVICE MARKET BY IMAGE GUIDING TECHNOLOGY

  • TABLE 32: GLOBAL MARKET FOR BIOPSY DEVICES BY IMAGE GUIDING TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
  • IMAGING TECHNOLOGIES USED IN GUIDING BIOPSIES
    • MRI-GUIDED BREAST BIOPSY
      • Advantages of MRI-Guided Biopsy
        • TABLE 33: GLOBAL MARKET FOR MRI-GUIDED BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • STEREOTACTIC-GUIDED BREAST BIOPSY
      • Advantages of Stereotactic-Guided Needle Biopsy
      • Disadvantages/Limitations of Stereotactic-Guided Needle Biopsy
        • TABLE 34: GLOBAL MARKET FOR STEREOTACTIC GUIDED BREAST BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
  • ULTRASOUND-GUIDED BIOPSY
    • LIVER BIOPSY
    • THYROID BIOPSY
    • PROSTATE BIOPSY
    • BREAST BIOPSY
    • TRENDS
      • TABLE 35: GLOBAL MARKET FOR ULTRASOUND-GUIDED BREAST BIOPSY BY REGION, THROUGH 2020 ($ MILLIONS)
  • COMPUTED TOMOGRAPHY
    • ADVANTAGES OF CT-GUIDED NEEDLE BIOPSY
    • DISADVANTAGES OF CT-GUIDED NEEDLE BIOPSY
    • LIMITATIONS OF CT-GUIDED NEEDLE BIOPSY
      • TABLE 36: GLOBAL MARKET FOR CT-GUIDED BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
  • OTHERS
    • TABLE 37: GLOBAL MARKET FOR OTHER BIOPSY IMAGING DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)

CHAPTER 7 - END USER MARKETS FOR BIOPSY DEVICES

  • TABLE 38: GLOBAL MARKET FOR BIOPSY DEVICES BY END USER, THROUGH 2020 ($ MILLIONS)
  • DIAGNOSTIC CENTERS
    • TABLE 39: GLOBAL MARKET FOR BIOPSY DEVICES USED IN DIAGNOSTIC CENTERS BY REGION, THROUGH 2020 ($ MILLIONS)
  • HOSPITALS
    • TABLE 40: GLOBAL MARKET FOR BIOPSY DEVICES USED IN HOSPITALS AND SPECIALIZED CENTERS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 41: GLOBAL MARKET FOR BIOPSY DEVICES USED BY SPECIALIZED CENTERS AND HOSPITALS, THROUGH 2020 ($ MILLIONS)
  • SPECIALIZED (CANCER)
    • TABLE 42: GLOBAL MARKET FOR BIOPSY DEVICES USED IN SPECIALIZED CENTERS BY REGION, THROUGH 2020 ($ MILLIONS)
  • HOSPITALS
    • TABLE 43: GLOBAL MARKET FOR BIOPSY DEVICES USED IN HOSPITALS BY REGION, THROUGH 2020 ($ MILLIONS)

CHAPTER 8 - COMPETITIVE LANDSCAPE

  • FIGURE 6: DISTRIBUTION OF KEY COMPETITIVE STRATEGIES USED BY BIOPSY DEVICE COMPANIES, 2012-2015 (%)
  • PRODUCT LAUNCHES
    • FIGURE 7 DISTRIBUTION OF PRODUCT LAUNCH STRATEGY BY COMPANY, 2012-2015 (%)
    • TABLE 44: KEY PRODUCT LAUNCHES ANNOUNCED BETWEEN 2012 AND 2015
  • PARTNERSHIPS AND COLLABORATIONS
    • FIGURE 8: DISTRIBUTION OF THE PARTNERSHIP AND COLLABORATION STRATEGY BY COMPANY, 2012-2015 (%)
    • TABLE 45: PARTNERSHIP AND COLLABORATION STRATEGY BY COMPANY, 2012-2015
  • ACQUISITIONS
    • FIGURE 9: DISTRIBUTION OF THE ACQUISITION STRATEGY BY COMPANY, 2012-2015 (%)
    • TABLE 46: COMPANY ACQUISITIONS , 2012-2015
  • EXPANSIONS
    • TABLE 47: COMPANY EXPANSIONS, 2012-2015

CHAPTER 9 - BIOPSY DEVICE MARKET BY REGION

  • NORTH AMERICA
    • TABLE 48: NORTH AMERICAN MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS)
  • EUROPE
    • TABLE 49: EUROPEAN MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS)
  • ASIA-PACIFIC
    • TABLE 50: ASIA-PACIFIC MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS)
  • ROW
    • TABLE 51: ROW MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS)

CHAPTER 10 - PATENT ANALYSIS

  • FIGURE 10: U.S., EUROPEAN AND JAPANESE SHARES OF PATENTS ON BIOPSY DEVICES, 2013-2015 (%)
  • U.S. PATENT ANALYSIS BY MARKET PARTICIPANT
    • FIGURE 11: U.S. PATENT SHARES BY MARKET PARTICIPANT, 2013-2015 (%)
  • EUROPEAN PATENT ANALYSIS BY MARKET PARTICIPANT
    • FIGURE 12: EUROPEAN PATENT SHARES BY MARKET PARTICIPANT, 2015 (%)
  • JAPANESE PATENT ANALYSIS BY MARKET PARTICIPANT
    • FIGURE 13: JAPANESE PATENT SHARES BY MARKET PARTICIPANT, 2013-2015 (%)

CHAPTER 11 - COMPANY PROFILES

  • ARGON MEDICAL DEVICES INC.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 52: ARGON MEDICAL DEVICES: RECENT DEVELOPMENTS
  • BECTON DICKINSON AND CO. (CAREFUSION CORP.)
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 53: BECTON DICKINSON (CAREFUSION): RECENT DEVELOPMENTS
      • TABLE 54: BECTON DICKINSON FINANCIALS ($ MILLIONS)
  • BOSTON SCIENTIFIC CORP.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 55: BOSTON SCIENTIFIC: RECENT DEVELOPMENTS
      • TABLE 56: BOSTON SCIENTIFIC FINANCIALS ($ MILLIONS)
  • C. R. BARD INC.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 57: C. R. BARD FINANCIALS ($ MILLIONS)
  • CARDINAL HEALTH INC.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 58: CARDINAL HEALTH: RECENT DEVELOPMENTS
      • TABLE 59: CARDINAL HEALTH FINANCIALS ($ MILLIONS)
  • COOK MEDICAL INC.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 60: COOK MEDICAL: RECENT DEVELOPMENTS
  • DTR MEDICAL LTD.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 61: DTR MEDICAL: RECENT DEVELOPMENTS
  • ETHICON ENDO-SURGERY INC.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 62: ETHICON ENDO-SURGERY: RECENT DEVELOPMENTS
      • TABLE 63: ETHICON ENDO-SURGERY (JOHNSON & JOHNSON) FINANCIALS ($ BILLIONS)
  • FUJIFILM HOLDINGS CORP.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 64: FUJIFILM HOLDINGS: RECENT DEVELOPMENTS
      • TABLE 65: FUJIFILM HOLDINGS FINANCIALS ($ MILLIONS)
  • HOLOGIC INC.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 66: HOLOGIC: RECENT DEVELOPMENTS
      • TABLE 67: HOLOGIC FINANCIALS ($ MILLIONS)
  • INRAD INC.
    • BIOPSY PRODUCT PORTFOLIO
  • INTACT MEDICAL CORP.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 68: INTACT MEDICAL: RECENT DEVELOPMENTS
  • LEICA BIOSYSTEMS (DEVICOR MEDICAL PRODUCTS)
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 69: LEICA BIOSYSTEMS (DEVICOR MEDICAL): RECENT DEVELOPMENTS
  • MAUNA KEA TECHNOLOGIES
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 70: MAUNA KEA TECHNOLOGIES: RECENT DEVELOPMENTS
      • TABLE 71: MAUNA KEA TECHNOLOGIES FINANCIALS ($ MILLIONS)
  • MDNA LIFE SCIENCES INC. (MITOMICS INC.)
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 72: MDNA LIFE SCIENCES (MITOMICS): RECENT DEVELOPMENTS
  • MDXHEALTH INC.
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 73: MDXHEALTH: RECENT DEVELOPMENTS
  • MEDTRONIC
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 74: MEDTRONIC: RECENT DEVELOPMENTS
      • TABLE 75: MEDTRONIC FINANCIALS ($ MILLIONS)
  • SANARUS TECHNOLOGIES LLC
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 76: SANARUS TECHNOLOGIES LLC: RECENT DEVELOPMENTS
  • VERAN MEDICAL TECHNOLOGIES
    • BIOPSY PRODUCT PORTFOLIO
      • TABLE 77: VERAN MEDICAL TECHNOLOGIES: RECENT DEVELOPMENTS

CHAPTER 12 - APPENDIX

  • TABLE 78: LIST OF NORTH AMERICAN PATENTS ON BIOPSY DEVICES, 2013-2015
  • TABLE 79: LIST OF EUROPEAN PATENTS ON BIOPSY DEVICES, 2013-2015
  • TABLE 80: LIST OF JAPANESE PATENTS ON BIOPSY DEVICES, 2013-2015

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 1: IMPLEMENTATION OF BREAST CANCER SCREENING PROGRAMS BY COUNTRY
    • TABLE 2: GLOBAL TRENDS IN AGING POPULATION BY REGION, 1980-2040 (%)
    • TABLE 3: PERCENTAGE OF THE AGING POPULATION IN DEVELOPING COUNTRIES, 2014 (%)
    • TABLE 4: GLOBAL MARKET FOR BIOPSY DEVICES BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 5: GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY TYPE, THROUGH 2020 ($ MILLIONS)
    • TABLE 6: TYPES OF BREAST BIOPSY AND MAMMOGRAPHY EQUIPMENT
    • TABLE 7: GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 8: GLOBAL MARKET FOR VACUUM-ASSISTED BREAST BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 9: GLOBAL MARKET FOR CORE NEEDLE BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 10: GLOBAL MARKET FOR FINE-NEEDLE ASPIRATION BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 11: GLOBAL MARKET FOR GASTROINTESTINAL BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 12: GLOBAL MARKET FOR SOFT TISSUE BIOPSY NEEDLES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 13: GLOBAL MARKET FOR BRONCHIAL BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 14: GLOBAL MARKET FOR GYNECOLOGICAL BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 15: GLOBAL MARKET FOR ROBOTIC GUIDANCE SYSTEMS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 16: GLOBAL MARKET FOR OTHER BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 17: TYPES OF BIOPSY CURETTES
    • TABLE 18: TYPES OF BIOPSY PUNCHES
    • TABLE 19: GLOBAL MARKET FOR BIOPSY DEVICES BY THERAPEUTIC AREA, THROUGH 2020 ($ MILLIONS)
    • TABLE 20: GLOBAL MARKET FOR BIOPSY DEVICE BY NUMBER OF PROCEDURES, THROUGH 2020 (THOUSANDS)
    • TABLE 21: GLOBAL MARKET FOR BREAST BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 22: GLOBAL MARKET FOR GI BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 23: GLOBAL MARKET FOR PROSTATE BIOPSY DEVICES THROUGH 2020 ($ MILLIONS)
    • TABLE 24: GLOBAL MARKET FOR LIVER BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 25: FIVE YEAR SURVIVAL RATES FOR NON-SMALL LUNG CANCER BY STAGE, 2013 (%)
    • TABLE 26: GLOBAL MARKET FOR LUNG BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 27: INCIDENCE OF KIDNEY CANCER IN THE U.S. BY GENDER, 2014 (%)
    • TABLE 28: GLOBAL MARKET FOR KIDNEY BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 29: DISTRIBUTION OF GYNECOLOGICAL CANCERS IN THE U.S. BY TYPE, 2014
    • TABLE 30: GLOBAL MARKET FOR GYNECOLOGICAL BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 31: GLOBAL MARKET FOR OTHER THERAPEUTIC BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 32: GLOBAL MARKET FOR BIOPSY DEVICES BY IMAGE GUIDING TECHNOLOGY, THROUGH 2020 ($ MILLIONS)
    • TABLE 33: GLOBAL MARKET FOR MRI-GUIDED BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 34: GLOBAL MARKET FOR STEREOTACTIC GUIDED BREAST BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 35: GLOBAL MARKET FOR ULTRASOUND-GUIDED BREAST BIOPSY BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 36: GLOBAL MARKET FOR CT-GUIDED BIOPSY DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 37: GLOBAL MARKET FOR OTHER BIOPSY IMAGING DEVICES BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 38: GLOBAL MARKET FOR BIOPSY DEVICES BY END USER, THROUGH 2020 ($ MILLIONS)
    • TABLE 39: GLOBAL MARKET FOR BIOPSY DEVICES USED IN DIAGNOSTIC CENTERS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 40: GLOBAL MARKET FOR BIOPSY DEVICES USED IN HOSPITALS AND SPECIALIZED CENTERS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 41: GLOBAL MARKET FOR BIOPSY DEVICES USED BY SPECIALIZED CENTERS AND HOSPITALS, THROUGH 2020 ($ MILLIONS)
    • TABLE 42: GLOBAL MARKET FOR BIOPSY DEVICES USED IN SPECIALIZED CENTERS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 43: GLOBAL MARKET FOR BIOPSY DEVICES USED IN HOSPITALS BY REGION, THROUGH 2020 ($ MILLIONS)
    • TABLE 44: KEY PRODUCT LAUNCHES ANNOUNCED BETWEEN 2012 AND 2015
    • TABLE 45: PARTNERSHIP AND COLLABORATION STRATEGY BY COMPANY, 2012-2015
    • TABLE 46: COMPANY ACQUISITIONS , 2012-2015
    • TABLE 47: COMPANY EXPANSIONS, 2012-2015
    • TABLE 48: NORTH AMERICAN MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS)
    • TABLE 49: EUROPEAN MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS)
    • TABLE 50: ASIA-PACIFIC MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS)
    • TABLE 51: ROW MARKET FOR BIOPSY DEVICES, THROUGH 2020 ($ MILLIONS)
    • TABLE 52: ARGON MEDICAL DEVICES: RECENT DEVELOPMENTS
    • TABLE 53: BECTON DICKINSON (CAREFUSION): RECENT DEVELOPMENTS
    • TABLE 54: BECTON DICKINSON FINANCIALS ($ MILLIONS)
    • TABLE 55: BOSTON SCIENTIFIC: RECENT DEVELOPMENTS
    • TABLE 56: BOSTON SCIENTIFIC FINANCIALS ($ MILLIONS)
    • TABLE 57: C. R. BARD FINANCIALS ($ MILLIONS)
    • TABLE 58: CARDINAL HEALTH: RECENT DEVELOPMENTS
    • TABLE 59: CARDINAL HEALTH FINANCIALS ($ MILLIONS)
    • TABLE 60: COOK MEDICAL: RECENT DEVELOPMENTS
    • TABLE 61: DTR MEDICAL: RECENT DEVELOPMENTS
    • TABLE 62: ETHICON ENDO-SURGERY: RECENT DEVELOPMENTS
    • TABLE 63: ETHICON ENDO-SURGERY (JOHNSON & JOHNSON) FINANCIALS ($ BILLIONS)
    • TABLE 64: FUJIFILM HOLDINGS: RECENT DEVELOPMENTS
    • TABLE 65: FUJIFILM HOLDINGS FINANCIALS ($ MILLIONS)
    • TABLE 66: HOLOGIC: RECENT DEVELOPMENTS
    • TABLE 67: HOLOGIC FINANCIALS ($ MILLIONS)
    • TABLE 68: INTACT MEDICAL: RECENT DEVELOPMENTS
    • TABLE 69: LEICA BIOSYSTEMS (DEVICOR MEDICAL): RECENT DEVELOPMENTS
    • TABLE 70: MAUNA KEA TECHNOLOGIES: RECENT DEVELOPMENTS
    • TABLE 71: MAUNA KEA TECHNOLOGIES FINANCIALS ($ MILLIONS)
    • TABLE 72: MDNA LIFE SCIENCES (MITOMICS): RECENT DEVELOPMENTS
    • TABLE 73: MDXHEALTH: RECENT DEVELOPMENTS
    • TABLE 74: MEDTRONIC: RECENT DEVELOPMENTS
    • TABLE 75: MEDTRONIC FINANCIALS ($ MILLIONS)
    • TABLE 76: SANARUS TECHNOLOGIES LLC: RECENT DEVELOPMENTS
    • TABLE 77: VERAN MEDICAL TECHNOLOGIES: RECENT DEVELOPMENTS
    • TABLE 78: LIST OF NORTH AMERICAN PATENTS ON BIOPSY DEVICES, 2013-2015
    • TABLE 79: LIST OF EUROPEAN PATENTS ON BIOPSY DEVICES, 2013-2015
    • TABLE 80: LIST OF JAPANESE PATENTS ON BIOPSY DEVICES, 2013-2015

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL MARKET FOR BIOPSY DEVICES BY REGION, 2014-2020 ($ MILLIONS)
    • FIGURE 1: GLOBAL TRENDS IN AGING POPULATION, 1980-2040 (%)
    • FIGURE 2: PERCENTAGE OF THE AGING POPULATION IN DEVELOPING COUNTRIES, 2014 (%)
    • FIGURE 3: FIVE-YEAR SURVIVAL RATE FOR NON-SMALL LUNG CANCER BY STAGE, 2013 (%)
    • FIGURE 4: INCIDENCE OF KIDNEY CANCER IN THE U.S. BY GENDER, 2014 (%)
    • FIGURE 5: DISTRIBUTION OF GYNECOLOGICAL CANCERS IN THE U.S. BY TYPE, 2014
    • FIGURE 6: DISTRIBUTION OF KEY COMPETITIVE STRATEGIES USED BY BIOPSY DEVICE COMPANIES, 2012-2015 (%)
    • FIGURE 7: DISTRIBUTION OF PRODUCT LAUNCH STRATEGY BY COMPANY, 2012-2015 (%)
    • FIGURE 8: DISTRIBUTION OF THE PARTNERSHIP AND COLLABORATION STRATEGY BY COMPANY, 2012-2015 (%)
    • FIGURE 9: DISTRIBUTION OF THE ACQUISITION STRATEGY BY COMPANY, 2012-2015 (%)
    • FIGURE 10: U.S., EUROPEAN AND JAPANESE SHARES OF PATENTS ON BIOPSY DEVICES, 2013-2015 (%)
    • FIGURE 11: U.S. PATENT SHARES BY MARKET PARTICIPANT, 2013-2015 (%)
    • FIGURE 12: EUROPEAN PATENT SHARES BY MARKET PARTICIPANT, 2015 (%)
    • FIGURE 13: JAPANESE PATENT SHARES BY MARKET PARTICIPANT, 2013-2015 (%)
Back to Top